We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
110 hedge funds and large institutions have $305M invested in Corcept Therapeutics in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 50 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 20
22% more capital invested
Capital invested by funds: $250M → $305M (+$55M)
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
1% more funds holding
Funds holding: 109 → 110 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
110
Holders Change
+1
Holders Change %
+0.92%
% of All Funds
2.94%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
50
Reduced
20
Closed
13
Calls
$561K
Puts
–
Net Calls
+$561K
Net Calls Change
+$201K
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$3.34M |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
-$3.25M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$824K |
| 4 |
First Eagle Investment Management
New York
|
-$575K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$561K |
